fulvestrant

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

FASLODEX — ASTRAZENECA, approved 2021-01-19 (NDA021344).

Most reported adverse events (US / FAERS)

35,082 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

malignant neoplasm progression

4,113

fatigue

4,102

nausea

2,947

death

2,707

Medicines containing this active substance

2 medicines

🇺🇸 Also approved in the US (FDA)

FASLODEX — ASTRAZENECA, approved 2021-01-19 (NDA021344).

Most reported adverse events (US / FAERS)

35,082 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

malignant neoplasm progression

4,113

fatigue

4,102

nausea

2,947

death

2,707

diarrhoea

2,542

neutropenia

2,437

white blood cell count decreased

2,159

neoplasm progression

2,128

metastases to bone

2,089

asthenia

1,730

pain

1,708

metastases to liver

1,688

breast cancer metastatic

1,604

dyspnoea

1,596

vomiting

1,532